Literature DB >> 12796194

Preoperative evaluation of patients undergoing lung resection surgery.

Debapriya Datta1, Bimalin Lahiri.   

Abstract

Lung cancer continues to be the leading case of cancer deaths in the United States. In patients with resectable non-small cell lung cancer, surgical resection is the treatment of choice. An accurate preoperative general and pulmonary-specific evaluation is essential as postoperative complications and morbidity of lung resection surgery are significant. After confirming anatomic resectability, patients must undergo a thorough evaluation to determine their ability to withstand the surgery and the loss of the resected lung. The measurement of spirometric indexes (ie, FEV(1)) and diffusing capacity of the lung for carbon monoxide (DLCO) should be performed first. If FEV(1) and DLCO are > 60% of predicted, patients are at low risk for complications and can undergo pulmonary resection, including pneumonectomy, without further testing. However, if FEV(1) and DLCO are < 60% of predicted, further evaluation by means of a quantitative lung scan is required. If lung scan reveals a predicted postoperative (ppo) values for FEV(1) and DLCO of > 40%, the patient can undergo lung resection. If the ppo FEV(1) and ppo DLCO are < 40%, exercise testing is necessary. If this reveals a maximal oxygen uptake (O(2)max) of > 15 mL/kg, surgery can be undertaken. If the O(2)max is < 15 mL/kg, surgery is not an option. This review discusses the existing modalities for preoperative evaluation prior to lung resection surgery.

Entities:  

Mesh:

Year:  2003        PMID: 12796194     DOI: 10.1378/chest.123.6.2096

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  41 in total

1.  Incidence, duration and causes of intensive care unit admission following pulmonary resection for malignancy.

Authors:  Daniel D Melley; Ewan M Thomson; Steve P Page; George Ladas; Jeremy Cordingley; Timothy W Evans
Journal:  Intensive Care Med       Date:  2006-07-07       Impact factor: 17.440

Review 2.  Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Authors:  Guy C Jones; Jason D Kehrer; Jenna Kahn; Bobby N Koneru; Ram Narayan; Tarita O Thomas; Kevin Camphausen; Minesh P Mehta; Aradhana Kaushal
Journal:  Clin Lung Cancer       Date:  2015-04-23       Impact factor: 4.785

Review 3.  Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC).

Authors:  Ying Liang; Heather A Wakelee
Journal:  Transl Lung Cancer Res       Date:  2013-10

Review 4.  Postoperative radiotherapy for non-small cell lung cancer.

Authors:  Sarah Burdett; Larysa Rydzewska; Jayne Tierney; David Fisher; Mahesh Kb Parmar; Rodrigo Arriagada; Jean Pierre Pignon; Cecile Le Pechoux
Journal:  Cochrane Database Syst Rev       Date:  2016-10-11

Review 5.  Lung cancer in elderly patients.

Authors:  Federico Venuta; Daniele Diso; Ilaria Onorati; Marco Anile; Sara Mantovani; Erino A Rendina
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data.

Authors:  R Arriagada; A Auperin; S Burdett; J P Higgins; D H Johnson; T Le Chevalier; C Le Pechoux; M K B Parmar; J P Pignon; R L Souhami; R J Stephens; L A Stewart; J F Tierney; H Tribodet; J van Meerbeeck
Journal:  Lancet       Date:  2010-03-24       Impact factor: 79.321

7.  Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial.

Authors:  Alda L Tam; Edward S Kim; J Jack Lee; Joe E Ensor; Marshall E Hicks; Ximing Tang; George R Blumenschein; Christine M Alden; Jeremy J Erasmus; Anne Tsao; Scott M Lippman; Waun K Hong; Ignacio I Wistuba; Sanjay Gupta
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

Review 8.  Exercise therapy across the lung cancer continuum.

Authors:  Lee W Jones; Neil D Eves; Emily Waner; Anil A Joy
Journal:  Curr Oncol Rep       Date:  2009-07       Impact factor: 5.075

9.  Oxygen Uptake Efficiency Slope and Prediction of Post-operative Morbidity and Mortality in Patients with Lung Cancer.

Authors:  Sertaç Yakal; Sevtün Sofyalı; Berker Özkan; Safinaz Yıldız; Alper Toker; Erdem Kasikcioglu
Journal:  Lung       Date:  2018-01-18       Impact factor: 2.584

10.  [Pulmonary function testing before ablative methods].

Authors:  R Ewert; C Opitz
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.